Metallic radionuclides possess a variety of half-lives, emission types, energies, and
branching ratios, making it possible to apply them as diagnostic and/or therapeutic agents …

Advances in the field of molecular biology have had an impact on biomedical applications,
which provide greater hope for both imaging and therapeutics. Work has been intensified on …

Antibiotic resistance is a significant public health issue, causing illnesses that were once
easily treatable with antibiotics to develop into dangerous infections, leading to substantial …

Glioma is the most common primary intracranial tumor without effective treatment. Positron
emission tomography tracers labeled with 68 Ga targeting fibroblast activation protein (FAP) …

Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Simple Summary Monoclonal antibody-bearing radionuclides have been under clinical
investigation over the last two decades for their use in theranostic (diagnostic and …

Targeted radionuclide therapy (TRNT) is an ever-expanding field of nuclear medicine that
provides a personalised approach to cancer treatment while limiting toxicity to normal …

Radiopharmaceuticals play a vital role in cancer therapy. The carrier of
radiopharmaceuticals can precisely locate and guide radionuclides to the target, where …

Systemic radioimmunotherapy (RIT) is arguably the most effective and least toxic anticancer
treatment for non-Hodgkin lymphoma (NHL). In treatment-naïve patients with indolent NHL …

Antibodies conjugated with diagnostic/therapeutic radionuclides are attractive options for
inoperable cancers lacking accurate imaging methods and effective therapeutics, such as …